tetano
Editor, Senior Moderator
Ann Afr Med
. 2025 Apr 14.
doi: 10.4103/aam.aam_230_24. Online ahead of print. Arteriovenous Thrombosis among Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients: An Observational Study at a University Hospital
[Article in French, English]
Abdullah Saleh AlAmri[SUP] 1 2 [/SUP], Mohammad S AlShahrani[SUP] 2 3 [/SUP], Tareq Mohammed Hejazi[SUP] 4 [/SUP], Hossain Abdulmohsen Abualola[SUP] 4 [/SUP], Adnan Taleb Samarah[SUP] 4 [/SUP], Mohammad Faisal Almuaigel[SUP] 1 5 [/SUP], Fahad Abdullah AlDawsar[SUP] 1 [/SUP], Nada S AlRashidi[SUP] 6 [/SUP], Mohannad Ali AlGhamdi[SUP] 3 [/SUP], Abdullah H Kabbani[SUP] 7 [/SUP]
Affiliations
in English, French
Context: The global spread of severe acute respiratory syndrome coronavirus 2 since its emergence in 2019 has led to widespread challenges in healthcare, prompting the World Health Organization to declare it a pandemic.
Aim: The aims of this study were to explore the prevalence of arterio-venous thrombosis (AVT) in COVID-19 patients, along with baseline characteristics and predictors of AVT.
Settings and design: This retrospective cohort study review of charts from adult patients presenting between March 1, 2020, and October 30, 2021, at King Fahd Hospital of the University.
Subjects and methods: Patients with both AVT and COVID-19 were included and categorized into groups: brain stroke, myocardial infarction (MI), pulmonary embolism (PE), and deep venous thrombosis (DVT). Demographic and clinical data were collected from electronic medical records, and patients were followed up 1 year after discharge.
Statistical analysis used: SPSS was used.
Results: Five hundred nine adult patients were admitted with COVID-19, and 195 were diagnosed with AVT. Brain stroke, MI, PE, and DVT were observed in 48.7%, 25.6%, 10.8%, and 14.9% of cases, respectively. Risk factors such as hypertension, diabetes, dyslipidemia, and smoking were more prevalent among stroke patients. Follow-up revealed varying mortality rates and recurrent AVT cases among different AVT syndromes.
Conclusions: The study highlights a higher incidence of AVT, particularly brain stroke, in COVID-19-positive patients, with overlapping AVT syndromes observed. The findings emphasize the intricate relationship between COVID-19 and AVT, necessitating further research and targeted interventions to address this critical aspect of the disease.
Keywords: AVC cérébral; Arterio-venous thrombosis; COVID-19; Thrombose arterioveineuse; brain stroke; deep venous thrombosis; embolie pulmonaire; infarctus du myocarde; myocardial infarction; pulmonary embolism; thrombose veineuse profonde.
. 2025 Apr 14.
doi: 10.4103/aam.aam_230_24. Online ahead of print. Arteriovenous Thrombosis among Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients: An Observational Study at a University Hospital
[Article in French, English]
Abdullah Saleh AlAmri[SUP] 1 2 [/SUP], Mohammad S AlShahrani[SUP] 2 3 [/SUP], Tareq Mohammed Hejazi[SUP] 4 [/SUP], Hossain Abdulmohsen Abualola[SUP] 4 [/SUP], Adnan Taleb Samarah[SUP] 4 [/SUP], Mohammad Faisal Almuaigel[SUP] 1 5 [/SUP], Fahad Abdullah AlDawsar[SUP] 1 [/SUP], Nada S AlRashidi[SUP] 6 [/SUP], Mohannad Ali AlGhamdi[SUP] 3 [/SUP], Abdullah H Kabbani[SUP] 7 [/SUP]
Affiliations
- PMID: 40229925
- DOI: 10.4103/aam.aam_230_24
in English, French
Context: The global spread of severe acute respiratory syndrome coronavirus 2 since its emergence in 2019 has led to widespread challenges in healthcare, prompting the World Health Organization to declare it a pandemic.
Aim: The aims of this study were to explore the prevalence of arterio-venous thrombosis (AVT) in COVID-19 patients, along with baseline characteristics and predictors of AVT.
Settings and design: This retrospective cohort study review of charts from adult patients presenting between March 1, 2020, and October 30, 2021, at King Fahd Hospital of the University.
Subjects and methods: Patients with both AVT and COVID-19 were included and categorized into groups: brain stroke, myocardial infarction (MI), pulmonary embolism (PE), and deep venous thrombosis (DVT). Demographic and clinical data were collected from electronic medical records, and patients were followed up 1 year after discharge.
Statistical analysis used: SPSS was used.
Results: Five hundred nine adult patients were admitted with COVID-19, and 195 were diagnosed with AVT. Brain stroke, MI, PE, and DVT were observed in 48.7%, 25.6%, 10.8%, and 14.9% of cases, respectively. Risk factors such as hypertension, diabetes, dyslipidemia, and smoking were more prevalent among stroke patients. Follow-up revealed varying mortality rates and recurrent AVT cases among different AVT syndromes.
Conclusions: The study highlights a higher incidence of AVT, particularly brain stroke, in COVID-19-positive patients, with overlapping AVT syndromes observed. The findings emphasize the intricate relationship between COVID-19 and AVT, necessitating further research and targeted interventions to address this critical aspect of the disease.
Keywords: AVC cérébral; Arterio-venous thrombosis; COVID-19; Thrombose arterioveineuse; brain stroke; deep venous thrombosis; embolie pulmonaire; infarctus du myocarde; myocardial infarction; pulmonary embolism; thrombose veineuse profonde.